• Selection Methodology
  • High Stakes Litigators
  • Acceptance Form
  • About Us
    • Our Mission
    • FAQ
    • Contact Us
  • Attorney Login
  • Selection Methodology
  • High Stakes Litigators
  • Acceptance Form
  • About Us
    • Our Mission
    • FAQ
    • Contact Us
  • Attorney Login
Menu
  • Home
  • About America’s Top 100 High Stakes Litigators
  • Account
    • Your Listings
  • Add Listing
  • Cart
  • Communication preferences
  • Complete Your Order
  • Contact Us
  • DISCLAIMERS & TERMS AND CONDITIONS OF USE
  • Edit Listing
  • Featured Recipients
  • Find the Plan That’s Right for You
  • Frequently Asked Questions
  • High Stakes Acceptance Form
  • High Stakes Litigators
    • Nevada
  • Listings
  • Log In / Register
  • Nominate an Attorney
  • Our Mission
  • Selection Methodology
  • Terms of Service
  • Thank You

Stephen R. Auten

Taft Stettinius & Hollister
Illinois
Intellectual Property LitigationPharmaceutical Litigation
111 East Wacker Drive, Suite 2800, Chicago, IL 60010

Stephen R. Auten

Taft Stettinius & Hollister
Illinois
Intellectual Property LitigationPharmaceutical Litigation
111 East Wacker Drive, Suite 2800, Chicago, IL 60010
(312) 427-4000
sauten@taftlaw.com
www.taftlaw.com
Get Directions

Bio

STEVE AUTEN is head of Taft's Pharmaceutical & Life Sciences Litigation practice area, as well as a firm of the firm’s Executive Committee. He is widely recognized in patent litigation, particularly Hatch-Waxman and biosimilar matters, and is followed by key industry leaders (brand and generic alike), law firms, analysts, educators, and others on his LinkedIn blog, "Hatch Waxman ANDA Litigation Forum" or HALF, which nearly 9,000 members worldwide. He currently represents clients primarily in the areas of Paragraph IV design strategies, Hatch-Waxman litigation, and biosimilar market opportunities. Prior to Taft, he led for several years the IP function for North America at Sandoz, a division of Novartis.

In addition to litigating Paragraph IV cases, Steve has served as a co-editor and chapter author on the following, leading treatises for pharmaceutical litigation: Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators, and Evidence in Patent Cases.

Steve is recognized by Chambers USA as a top Intellectual Property attorney in Illinois, as well as by his peers in The Best Lawyers in America for IP Litigation, as an Illinois Leading Lawyer, an Illinois Super Lawyer in IP Litigation, and as a "World's Leading Patent Practitioner" by Intellectual Asset Management magazine. In 2018, Steve was also one of a handful of national finalists for LMG Life Sciences’ award of “Hatch-Waxman Litigator of the Year – Generic.”

Client comments from the 2018 Chambers Review recommend Steve for his “very pragmatic” counsel on Hatch-Waxman matters, and note that “he is resourceful, knowledgeable and gets back to you immediately when you need advice.” Client comments for IAM’s Patent 1000 similarly echo that Steve is “one of the most knowledgeable ANDA litigation experts” who “has the right answer for any question.” He’s ready to answer yours.

Nominate An Attorney







    Find Featured Recipients

    Attorney Acceptance Form

    Attorney Login

    • facebook
    • linkedin

    Copyright 2025 © America’s Top 100 LLC. All Rights Reserved | Digital Marketing by Incredible Marketing

    Login


    Lost your password?

    Sign up for America's Top 100 High Stakes Litigators